Express Pharma (Vol.11, No.11) April 1-15, 2016

Read more

Lupin clarifies on from 483s issued by US FDA for its Mandideep facility

Read more

Govt’s decision to ban 344 FDCs was taken without consideration: Pharma cos to Delhi HC

Read more

Sun Pharma enters Japanese prescription market

Read more

Jubilant Innovation USA to receive up to $22.6 m over acquisition of drug development firm

Read more

Cadila gets US FDA nod to sell generic anti-viral drug

Read more

Aurobindo Pharma receives US FDA approval for rivastigmine tartrate capsules

Read more

Zydus acquires gastro therapy ‘Actibile’ from Albert David

Read more

Panacea Biotec launches CABAPAN

Read more

Biocon’s Insulin Glargine receives regulatory approval in Japan

Read more